Business Description
International Biotechnology Trust PLC
SIC : 6726
ISIN : GB0004559349
Description
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 78.7 | |||||
3-Year EPS without NRI Growth Rate | 60.8 | |||||
3-Year FCF Growth Rate | 210.2 | |||||
3-Year Book Growth Rate | 2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.57 | |||||
9-Day RSI | 47.08 | |||||
14-Day RSI | 49.21 | |||||
3-1 Month Momentum % | 11.28 | |||||
6-1 Month Momentum % | 18.39 | |||||
12-1 Month Momentum % | 59.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.83 | |||||
Dividend Payout Ratio | 0.13 | |||||
3-Year Dividend Growth Rate | 0.3 | |||||
Forward Dividend Yield % | 2.83 | |||||
5-Year Yield-on-Cost % | 3.4 | |||||
3-Year Average Share Buyback Ratio | 6.2 | |||||
Shareholder Yield % | 9.71 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Net Margin % | 99 | |||||
FCF Margin % | -7.63 | |||||
OCF Margin % | -7.63 | |||||
ROE % | 27.6 | |||||
ROA % | 24.45 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 4.59 | |||||
PE Ratio without NRI | 4.59 | |||||
Shiller PE Ratio | 23.9 | |||||
PS Ratio | 4.54 | |||||
PB Ratio | 1.12 | |||||
Price-to-Tangible-Book | 1.12 | |||||
Price-to-Free-Cash-Flow | 9.97 | |||||
Price-to-Operating-Cash-Flow | 9.97 | |||||
EV-to-Forward-EBIT | -11 | |||||
EV-to-Revenue | 4.86 | |||||
EV-to-FCF | 10.03 | |||||
Price-to-Projected-FCF | 1.25 | |||||
Price-to-Graham-Number | 0.48 | |||||
FCF Yield % | 10.89 | |||||
Forward Rate of Return (Yacktman) % | 2.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
International Biotechnology Trust PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 80.436 | ||
| EPS (TTM) (£) | 2.401 | ||
| Beta | 0.7056 | ||
| 3-Year Sharpe Ratio | 0.74 | ||
| 3-Year Sortino Ratio | 1.26 | ||
| Volatility % | 24.73 | ||
| 14-Day RSI | 49.21 | ||
| 14-Day ATR (£) | 0.31347 | ||
| 20-Day SMA (£) | 11.185 | ||
| 12-1 Month Momentum % | 59.5 | ||
| 52-Week Range (£) | 6.7 - 12.35 | ||
| Shares Outstanding (Mil) | 31.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
International Biotechnology Trust PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
International Biotechnology Trust PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-11 12:00 | In 86 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-11-06 11:00 | In 51 days | ||
| Annual report for 2026 | 2026-11-06 | In 50 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-06 | In 50 days | ||
| GBP 0.156700 Cash Dividend | 2026-07-23 | 11.05 (-3.07%) | ||
| Second quarter earnings conference call for 2026 | 2026-05-12 08:00 | 9.90 (+2.27%) | ||
| Second quarter earnings results for 2026 | 2026-05-12 | 9.90 (+2.27%) | ||
| GBP 0.156400 Cash Dividend | 2025-12-29 | 9.80 (+0.00%) | ||
| General meeting for 2025 | 2025-12-12 12:00 | 9.74 (+0.41%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-11-06 11:00 | 8.26 (-1.67%) |
Show
Entries
International Biotechnology Trust PLC Frequently Asked Questions
What is International Biotechnology Trust PLC(LSE:IBT)'s stock price today?
The current price of LSE:IBT is £11.05. The 52 week high of LSE:IBT is £12.35 and 52 week low is £6.70.
When is next earnings date of International Biotechnology Trust PLC(LSE:IBT)?
The next earnings date of International Biotechnology Trust PLC(LSE:IBT) is 2026-11-06 Est..
Does International Biotechnology Trust PLC(LSE:IBT) pay dividends? If so, how much?
The Dividend Yield %  of International Biotechnology Trust PLC(LSE:IBT) is 2.83% (As of Today), Highest Dividend Payout Ratio of International Biotechnology Trust PLC(LSE:IBT) was 1.68. The lowest was 0.13. And the median was 0.35. The  Forward Dividend Yield % of International Biotechnology Trust PLC(LSE:IBT) is 2.83%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers